Dr. Dirk Lange

Dr. Dirk Lange

B.Sc. Hon McMaster University, Hamilton, Ontario
Ph.D. University of Western Ontario, London, Ontario

Team: 
Associate Members
Positions: 

Assistant Professor, Department of Urologic Sciences, University of British Columbia
Director of Basic Science Research, The Stone Centre at VGH

 

Dr. Dirk Lange is a microbiologist who earned his Ph.D. in Microbiology and Immunology from the University of Western Ontario (London, Ontario). Since joining the Department of Urologic Sciences at the University of British Columbia, Vancouver, Canada in 2008 as a postdoctoral fellow and transitioning into a faculty position in 2011, he has been instrumental in developing a translational research program at The Stone Centre at Vancouver General Hospital focused on the treatment of kidney stone disease. One of his major contributions to the field has been in the area of ureteral stent biomaterial design, where he has done extensive work on understanding mechanisms that drive ureteral stent-associated complications including bacterial biofilm formation and device encrustation. Furthermore, Dr. Lange is actively involved in the development of novel anti-fouling coatings for medical devices including ureteral stents and urinary catheters, as well as the development of a biodegradable ureteral stent. Furthermore, given his background in Microbiology & Immunology, Dr. Lange’s research program also involves studying the role of the intestinal microbiome in recurrent kidney stone disease. Given his contributions to benign urology, he was recently named a Urology Care Foundation Research Scholar and the 2015 Outstanding Graduating Scholar by the American Urological Association Office of Research.

Aside from his contributions to benign urology, Dr. Lange’s expertise has been leveraged directly to contributions to collaborative studies in bladder and prostate cancer. As an example, Dr. Lange is actively involved in developing novel bacterial-based alternatives to BCG for the treatment of superficial bladder cancer, and has contributed significantly to studies in the Department looking at the prevention of sepsis following prostate biopsy.

Dr. Lange’s unique background brings a new perspective on various aspects of urological research and has helped foster a vibrant interactive research community in the renal/bladder research group of the Department of Urologic Sciences and the Vancouver Prostate Centre.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Conference Flyer Page 1

Breast & Prostate Cancer half-day virtual conference: Saturday, September 18th, 2021

The What you Need to Know for Your Patients Post Breast & Prostate Cancer Conference, taking place online on Saturday, September 18th, 2021 from 8:00am – 1:30pm, is an accredited virtual half-day conference focusing on screening, treatment, side-effect management & emerging new therapies for breast & prostate cancer patients. Click here for more information and to register. 

Dr. Peter Black, team captain

Terry Fox Run fundraiser: September 19th, 2021

The 41st Annual Terry Fox Run is taking place on Sunday September 19, 2021. If you are able, please consider donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research. 

Employment

Work at the Vancouver Prostate Centre

Wednesday, September 8, 2021

Recent publication proposes a potential new therapeutic approach to treatment-resistant prostate cancer

Tuesday, August 3, 2021

Dr. Cherkasov receives 2021 Faculty of Medicine Distinguished Achievement Award

Dr. Cherkasov